Alpha Emitters Market
Alpha Emitters Market Size, Share, Trends, Growth, Forecast Analysis, By Type of Radionuclide (Radium, Lead, Bismuth, Actinium), By Application (Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma, Lymphoma) & By Region - Global Market Insights 2022-2032
Analysis of Alpha Emitters Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Alpha Emitters Market Outlook (2022-2032)
According to the alpha emitters market report by Fact.MR, a market research and competitive intelligence provider, the global market is valued at US$ 1 billion in 2022 and is expected to surge ahead at an astounding CAGR of 21% to reach US$ 6.7 billion by the end of 2032.
Based on application, alpha emitters are classified into bone metastasis, ovarian cancer, pancreatic cancer, melanoma, lymphoma, and others. Radium, lead, bismuth, and others are used in alpha emitters, which are useful in treatment procedures such as metastatic solid tumors (pancreatic cancer).
Demand for alpha emitters for use in ovarian cancer medical applications is predicted to rise rapidly at a CAGR of 22% from 2022 to 2032. This can be primarily attributed to the rise in ovarian cancer cases across the world.
A very important role is played by alpha emitters in the therapy of cancer. There are significant distinctions between this discipline of nuclear medicine and other fields due to the characteristics of alpha emitters. Alpha particles have been significantly taken into consideration in medical research due to their limited range and high LET (deposit energy in a unit length of their passage).
The subatomic particles known as alpha particles are made up of two neutrons and two protons. To restore balance, alpha particles are released when the nucleus of an atom gets unstable (the number of neutrons to protons is very low).
High atomic number elements such as radium, uranium, and thorium experience alpha decay. These elements' nuclei contain a lot of neutrons, which allows for the emission of alpha particles. Because alpha particles are sluggish and relatively heavy, they have little penetration strength and can be stopped by a piece of paper.
It is well known that alpha particles can significantly damage tumour cells. They directly harm the DNA of the cell in an irreparable way, which results in cell death.
However, the alpha particle's range of motion in tissue is relatively constrained. Consequently, using alpha particles as a locally delivered therapy for solid tumours was not possible until now.
?To get over the short-range restriction of alpha particles, the Alpha DaRTTM technology uses the diffusion of atoms that emit alpha particles into the tumour tissue. The extensive region that alpha radiation may cover makes it possible to potentially treat the entire tumour.
The Alpha DaRT method relies on tiny, incredibly precise doses of radioactive radium-224 attached to metal sources placed inside the tumour. The short-lived radioactive atoms are released when radium-224 decays and disseminate throughout the tumour. These atoms produce short-range alpha radiation, which quickly damages and kills cancerous cells.
Alpha DaRT has special qualities that may considerably improve the effectiveness, safety, and ease of cancer treatment, including higher linear energy transfer, irreversible break of both DNA, potential utility in all solid tumour types, minimal capital funding, ultra-minimally invasive application, and more.
The substantial and sophisticated research and development efforts being carried out in the field of cancer therapy are the main factors driving the growth of the alpha emitters market. This is related to the emerging understanding of targeted alpha emitters' capacity to kill cells.
In accordance with this, the market is being stimulated by the increasing frequency of different types of cancer among the populace. Additionally, a bright market for alpha emitters is being created by the growing senior population, which is sensitive to several cardiac and cancer disorders.
Furthermore, increased use of targeted anticancer or alpha therapy (TAT) in healthcare institutions is generating more opportunities in the alpha emitters market.
Report Attributes |
Details |
|---|---|
|
Alpha Emitters Market Size (2022E) |
US$ 1 Billion |
|
Forecasted Market Value (2032F) |
US$ 6.7 Billion |
|
Global Market Growth Rate (2022-2032) |
21% CAGR |
|
China Market Growth Rate (2022-2032) |
20% CAGR |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Why are Sales of Alpha Emitters Rising So Rapidly?
“Large Population Living with Various Forms of Cancer”
Demand for alpha emitters is projected to rise as a result of rising consumer knowledge of the targeted alpha emitter's potential advantages and a large patient population suffering from various malignancies, including ovarian, pancreatic, lymphoma, melanoma, and others.
Furthermore, the application of targeted anticancer or alpha therapy in the treatment of cancer is expanding, as alpha particles have significance in targeted therapy due to their extraordinarily high capacity to kill cells.
- For instance, the International Agency for Research on Cancer (IARC) projects that by 2040, there would be 16.3 million cancer deaths and 27.5 million cancer occurrences worldwide, mostly as a result of senior population growth. In low- and middle-income nations, cancer deaths account for about 70% of all fatalities.
As a result, it is anticipated that there would be a rise in the need for radiopharmaceuticals to treat cardiovascular and cancer-related disorders.
As more chronic diseases are being treated with alpha-targeted therapies, key manufacturers in the alpha emitters market are becoming more aware of their potential benefits. Short-range, high-efficiency α-particle radioimmunotherapy is an innovative and promising therapeutic strategy. Targeted therapy benefits from the very high cell-killing capacity of α-particles.
What Should Manufacturers of Alpha Emitters Be Aware Of?
“Strict Regulatory Policies to Hamper Sales of Alpha Emitters”
Clinical research and translational studies are hampered by regulatory rules. For example, the FDA in the United States regulates all pharmacologic agents, including diagnostic radiopharmaceuticals and radiotherapies.
Similar to this, radiopharmaceuticals go through particular regulatory and approval processes worldwide and are subject to increased scrutiny. This may hinder the sales growth of alpha emitters.
Which Region is Expected to Lead Global Sales of Alpha Emitters?
“Rising Cases of Cardiological & Cancerous Disorders in North America”
Currently, North America dominates the global alpha emitters market and it is anticipated that this dominance will continue throughout the forecast period as well due to the rising cardiological and cancerous disorders in the region.
- For instance, a trial including ten patients with malignant skin and soft tissue tumours revealed that the Alpha DaRT, diffusing alpha-emitter radiation therapy, produced complete responses (CRs) in accordance with RECIST v1.1 criteria.
- In the United States, Alpha Tau Medical Ltd. began a multi-center pivotal trial for skin cancer in 2022.
Cancer is the second-largest cause of death and morbidity in Europe. This creates wide opportunities for the manufacturers of alpha emitters during the forecast period.
Rise in the adoption of innovative products and an increase in the prevalence of cancer in developing countries such as China, Japan, and India are expected to fuel the sales growth of the Asia Pacific market.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis
What Makes the U.S. a Leading Market for Alpha Emitters in North America?
“Rising Cases of Cancer Augmenting Sales of Alpha Emitters”
One of the most common causes of chronic illness in the United States is cancer.
- According to projections by the American Cancer Society, the United States would experience 1.9 million fresh cancer cases and 609,360 cancer-related fatalities in 2022.
The oncology market in the United States is expanding, which is fueling the demand for alpha emitters. This number is anticipated to rise significantly in the coming years.
How is Demand for Alpha Emitters Progressing in European Countries?
“High Demand from Nuclear Medicine & Radiopharmaceutical Applications”
As there is high demand for alpha emitters from nuclear medicine and radiopharmaceutical applications, Germany holds an impressive share in the Europe alpha emitters market, followed by France, Italy, the United Kingdom, and Spain.
Due to the presence of numerous large and small businesses with comparable product offerings, the market for alpha emitters in European countries is very competitive. To raise their market shares and gain a firm presence in the European market, these organisations employ a variety of tactics such as agreements, acquisitions, market developments, website launches, marketing and promotional activities, and technological advancements.
Category-wise Analysis
Why is Demand for Alpha Emitters High for Ovarian Cancer Treatment?
“Ovarian Cancer Leading to High Number of Deaths”
- Ovarian cancer is the fifth most prevalent cancer-related cause of death among women in the United States, according to the American Cancer Society. The American Cancer Society predicts that 19,880 women will be newly diagnosed with ovarian cancer in the U.S. in 2022. Ovarian cancer will claim the lives of approximately 12,810 women.
The main market participants are concentrating on creating cutting-edge radionuclides for the treatment of various forms of ovarian cancer.
For example,
- January 2021: Soricimed Biopharma Inc. and Orano Med decided to concentrate on the creation of an advancedPeptide Receptor Radionuclide Therapy to treat solid tumour cancers.
The businesses are examining the potential of this cutting-edge strategy for the treatment of cancer using Soricimed's TRPV6 cancer receptor-targeting peptides and Orano Med's special radioactive alpha emitter, lead-212 (212Pb).
Radioimmunotherapy is used as a locally administered adjuvant therapy for ovarian cancer. Trials have examined the use of non-specific IP radiation, moving-strip EBRT, or total abdominal EBRT with colloid preparations of Au-198 or P-32 as adjuvant treatments.
Targeted alpha therapy using shorter wavelengths and higher LET has shown promise in the therapeutic process. Projection forecasts indicate that this trend will continue to expand in the coming years.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
There are only a few significant companies in this less-competitive alpha emitters sector.
Actinium Pharmaceuticals, Inc., Alpha Tau Medical, Bayer AG, Fusion Pharma, Lantheus Medical Imaging, Inc., NTP Radiosotopes SOC Ltd., RadioMedix, Inc., Siemens Healthineers, and Triad Isotopes, Inc. are some of the key players in the alpha emitters market.
- A formal business merger agreement was signed by Healthcare Capital Corp. and Alpha Tau Medical Limited in July 2021. This deal is used to further Alpha Tau's clinical plan, which includes pursuing FDA marketing permission, engaging in a wide range of R&D initiatives, increasing manufacturing capability, and getting ready for commercialization.
Key Segments in Alpha Emitters Industry Research
-
By Type of Radionuclide:
- Radium
- Lead
- Bismuth
- Actinium
-
By Application:
- Bone Metastasis
- Ovarian Cancer
- Pancreatic Cancer
- Melanoma
- Lymphoma
-
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Type of Radionuclide modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Type of Radionuclide USPs /Technology 4.4. List of Manufacturers and Providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New Type of Radionuclide launches 5.2.2. Cost of Type of Radionuclides 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1. Current COVID19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as Compared to 2008 Economic analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue By Type of Radionuclide 6.4.2. Revenue By Application 6.4.3. Revenue By Country 6.5. 2021 Market Scenario 6.6. Quarter by Quarter Forecast 6.7. Projected Recovery Quarter 7. Global Alpha Emitters Market Volume (Units) Analysis 2017-2021 and Forecast, 2022-2032 7.1. Historical Market Volume (Units) Analysis, 2017-2021 7.2. Current and Future Market Volume (Units) Projections, 2022-2032 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Alpha Emitters Market - Pricing Analysis 8.1. Regional Pricing Analysis By Type of Radionuclide 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Alpha Emitters Market Value Analysis 2017–2021 and Forecast, 2022-2032 9.1. Historical Market Value (US$ Mn) Analysis, 2017–2021 9.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Alpha Emitters Market Analysis 2017–2021 and Forecast 2022-2032, by Type of Radionuclide 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Type of Radionuclides & Services, 2017–2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type of Radionuclide, 2022-2032 10.3.1. Radium 10.3.2. Lead 10.3.3. Bismuth 10.3.4. Actinium 10.4. Market Attractiveness Analysis By Type of Radionuclide 11. Global Alpha Emitters Market Analysis 2017–2021 and Forecast 2022-2032, by Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Application , 2017–2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application , 2022-2032 11.3.1. Bone Metastasis 11.3.2. Ovarian Cancer 11.3.3. Pancreatic Cancer 11.3.4. Melanoma 11.3.5. Lymphoma 11.4. Market Attractiveness Analysis By Application 12. Global Alpha Emitters Market Analysis 2017–2021 and Forecast 2022-2032, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2032 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Alpha Emitters Market Analysis 2017–2021 and Forecast 2022-2032 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Type of Radionuclide 13.3.3. By Application 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Alpha Emitters Market Analysis 2017–2021 and Forecast 2022-2032 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Type of Radionuclide 14.3.3. By Application 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Alpha Emitters Market Analysis 2017–2021 and Forecast 2022-2032 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Type of Radionuclide 15.3.3. By Application 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Alpha Emitters Market Analysis 2017–2021 and Forecast 2022-2032 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Type of Radionuclide 16.3.3. By Application 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Alpha Emitters Market Analysis 2017–2021 and Forecast 2022-2032 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Type of Radionuclide 17.3.3. By Application 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Alpha Emitters Market Analysis 2017–2021 and Forecast 2022-2032 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Type of Radionuclide 18.3.3. By Application 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Alpha Emitters Market Analysis 2017–2021 and Forecast 2022-2032 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Type of Radionuclide 19.3.3. By Application 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Alpha Emitters Market Analysis 2017–2021 and Forecast 2022-2032 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Alpha Emitters Market Analysis 20.2.1. By Type of Radionuclide 20.2.2. By Application 20.3. Canada Alpha Emitters Market Analysis 20.3.1. By Type of Radionuclide 20.3.2. By Application 20.4. Mexico Alpha Emitters Market Analysis 20.4.1. By Type of Radionuclide 20.4.2. By Application 20.5. Brazil Alpha Emitters Market Analysis 20.5.1. By Type of Radionuclide 20.5.2. By Application 20.6. U.K. Alpha Emitters Market Analysis 20.6.1. By Type of Radionuclide 20.6.2. By Application 20.7. Germany Alpha Emitters Market Analysis 20.7.1. By Type of Radionuclide 20.7.2. By Application 20.8. France Alpha Emitters Market Analysis 20.8.1. By Type of Radionuclide 20.8.2. By Application 20.9. Italy Alpha Emitters Market Analysis 20.9.1. By Type of Radionuclide 20.9.2. By Application 20.10. Spain Alpha Emitters Market Analysis 20.10.1. By Type of Radionuclide 20.10.2. By Application 20.11. BENELUX Alpha Emitters Market Analysis 20.11.1. By Type of Radionuclide 20.11.2. By Application 20.12. Russia Alpha Emitters Market Analysis 20.12.1. By Type of Radionuclide 20.12.2. By Application 20.13. China Alpha Emitters Market Analysis 20.13.1. By Type of Radionuclide 20.13.2. By Application 20.14. Japan Alpha Emitters Market Analysis 20.14.1. By Type of Radionuclide 20.14.2. By Application 20.15. South Korea Alpha Emitters Market Analysis 20.15.1. By Type of Radionuclide 20.15.2. By Application 20.16. India Alpha Emitters Market Analysis 20.16.1. By Type of Radionuclide 20.16.2. By Application 20.17. ASEAN Alpha Emitters Market Analysis 20.17.1. By Type of Radionuclide 20.17.2. By Application 20.18. Australia Alpha Emitters Market Analysis 20.18.1. By Type of Radionuclide 20.18.2. By Application 20.19. New Zealand Alpha Emitters Market Analysis 20.19.1. By Type of Radionuclide 20.19.2. By Application 20.20. GCC Countries Alpha Emitters Market Analysis 20.20.1. By Type of Radionuclide 20.20.2. By Application 20.21. Turkey Alpha Emitters Market Analysis 20.21.1. By Type of Radionuclide 20.21.2. By Application 20.22. South Africa Alpha Emitters Market Analysis 20.22.1. By Type of Radionuclide 20.22.2. By Application 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Type of Radionuclide foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. Actinium Pharmaceuticals, Inc. 22.3.1.1. Overview 22.3.1.2. Type of Radionuclide Portfolio 22.3.1.3. Profitability by Market Segments (Type of Radionuclide/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.2. Alpha Tau Medical 22.3.2.1. Overview 22.3.2.2. Type of Radionuclide Portfolio 22.3.2.3. Profitability by Market Segments (Type of Radionuclide/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.3. Bayer AG 22.3.3.1. Overview 22.3.3.2. Type of Radionuclide Portfolio 22.3.3.3. Profitability by Market Segments (Type of Radionuclide/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.4. Fusion Pharma 22.3.4.1. Overview 22.3.4.2. Type of Radionuclide Portfolio 22.3.4.3. Profitability by Market Segments (Type of Radionuclide/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.5. IBA Group 22.3.5.1. Overview 22.3.5.2. Type of Radionuclide Portfolio 22.3.5.3. Profitability by Market Segments (Type of Radionuclide/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.6. IBA Radiopharma Solutions 22.3.6.1. Overview 22.3.6.2. Type of Radionuclide Portfolio 22.3.6.3. Profitability by Market Segments (Type of Radionuclide/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.7. Lantheus Medical Imaging, Inc. 22.3.7.1. Overview 22.3.7.2. Type of Radionuclide Portfolio 22.3.7.3. Profitability by Market Segments (Type of Radionuclide/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.8. NTP Radiosotopes SOC Ltd. 22.3.8.1. Overview 22.3.8.2. Type of Radionuclide Portfolio 22.3.8.3. Profitability by Market Segments (Type of Radionuclide/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.9. RadioMedix, Inc. 22.3.9.1. Overview 22.3.9.2. Type of Radionuclide Portfolio 22.3.9.3. Profitability by Market Segments (Type of Radionuclide/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.10. Siemens Healthineers 22.3.10.1. Overview 22.3.10.2. Type of Radionuclide Portfolio 22.3.10.3. Profitability by Market Segments (Type of Radionuclide/Channel/Region) 22.3.10.4. Sales Footprint 22.3.10.5. Strategy Overview 22.3.11. Telix Pharmaceuticals Ltd. 22.3.11.1. Overview 22.3.11.2. Type of Radionuclide Portfolio 22.3.11.3. Profitability by Market Segments (Type of Radionuclide/Channel/Region) 22.3.11.4. Sales Footprint 22.3.11.5. Strategy Overview 22.3.12. Triad Isotopes, Inc. 22.3.12.1. Overview 22.3.12.2. Type of Radionuclide Portfolio 22.3.12.3. Profitability by Market Segments (Type of Radionuclide/Channel/Region) 22.3.12.4. Sales Footprint 22.3.12.5. Strategy Overview 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Alpha Emitters Market Volume (‘000 Units) Analysis and Opportunity Assessment 2017–2032, By Type of Radionuclide
Table 02: Global Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Type of Radionuclide
Table 03: Global Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Application
Table 04: Global Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Region
Table 05: North America Alpha Emitters Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, By Country
Table 06: North America Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Type of Radionuclide
Table 07: North America Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Application
Table 08: Latin America Alpha Emitters Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, By Country
Table 09: Latin America Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Type of Radionuclide
Table 10: Latin America Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Application
Table 11: Europe Alpha Emitters Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, By Country
Table 12: Europe Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Type of Radionuclide
Table 13: Europe Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Application
Table 14: South Asia Alpha Emitters Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, By Country
Table 15: South Asia Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Type of Radionuclide
Table 16: South Asia Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Application
Table 17: East Asia Alpha Emitters Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, By Country
Table 18: East Asia Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Type of Radionuclide
Table 19: East Asia Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Application
Table 20: Oceania Alpha Emitters Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, By Country
Table 21: Oceania Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Type of Radionuclide
Table 22: Oceania Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Application
Table 23: Middle East and Africa Alpha Emitters Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, By Country
Table 24: Middle East and Africa Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Type of Radionuclide
Table 25: Middle East and Africa Alpha Emitters Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2032, By Application
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Alpha Emitters Market Volume (in 000' Units) Analysis, 2017-2021
Figure 02: Global Alpha Emitters Market Volume Forecast (in 000' Units), 2022-2032
Figure 03: Alpha Emitters Pricing Analysis (US$) Per Type of Radionuclide, By Region, 2021
Figure 04: Alpha Emitters Pricing Analysis (US$) Per Type of Radionuclide, By Region, 2021
Figure 05: Global Alpha Emitters Market Value Analysis (US$ Mn), 2017-2021
Figure 06: Global Alpha Emitters Market Value Forecast (US$ Mn), 2022-2032
Figure 07: Global Alpha Emitters Market Absolute $ Opportunity, 2022-2032
Figure 08: Global Alpha Emitters Market Share Analysis (%), By Type of Radionuclide, 2022-2032
Figure 09: Global Alpha Emitters Market Y-o-Y Analysis (%), By Type of Radionuclide, 2022-2032
Figure 10: Global Alpha Emitters Market Attractiveness Analysis by Type of Radionuclide, 2022-2032
Figure 11: Global Alpha Emitters Market Share Analysis (%), By Application, 2022-2032
Figure 12: Global Alpha Emitters Market Y-o-Y Analysis (%), By Application, 2022-2032
Figure 13: Global Alpha Emitters Market Attractiveness Analysis by Application, 2022-2032
Figure 14: Global Alpha Emitters Market Share Analysis (%), By Region, 2022-2032
Figure 15: Global Alpha Emitters Market Y-o-Y Analysis (%), By Region, 2022-2032
Figure 16: Global Alpha Emitters Market Attractiveness Analysis by Region, 2022-2032
Figure 17: North America Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 18: North America Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 19: North America Alpha Emitters Market Value Share, By Country, 2022 (E)
Figure 20: North America Alpha Emitters Market Value Analysis (US$ Mn), 2017-2021
Figure 21: North America Alpha Emitters Market Value Forecast (US$ Mn), 2022-2032
Figure 22: North America Alpha Emitters Market Attractiveness Analysis by Type of Radionuclide, 2022-2032
Figure 23: North America Alpha Emitters Market Attractiveness Analysis by Application, 2022-2032
Figure 24: North America Alpha Emitters Market Attractiveness Analysis by Country, 2022-2032
Figure 25: Latin America Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 26: Latin America Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 27: Latin America Alpha Emitters Market Value Share, By Country, 2022 (E)
Figure 28: Latin America Alpha Emitters Market Value Analysis (US$ Mn), 2017-2021
Figure 29: Latin America Alpha Emitters Market Value Forecast (US$ Mn), 2022-2032
Figure 30: Latin America Alpha Emitters Market Attractiveness Analysis by Type of Radionuclide, 2022-2032
Figure 31: Latin America Alpha Emitters Market Attractiveness Analysis by Application, 2022-2032
Figure 32: Latin America Alpha Emitters Market Attractiveness Analysis by Country, 2022-2032
Figure 33: Europe Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 34: Europe Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 35: Europe Alpha Emitters Market Value Share, By Country, 2022 (E)
Figure 36: Europe Alpha Emitters Market Value Analysis (US$ Mn), 2017-2021
Figure 37: Europe Alpha Emitters Market Value Forecast (US$ Mn), 2022-2032
Figure 38: Europe Alpha Emitters Market Attractiveness Analysis by Type of Radionuclide, 2022-2032
Figure 39: Europe Alpha Emitters Market Attractiveness Analysis by Application, 2022-2032
Figure 40: Europe Alpha Emitters Market Attractiveness Analysis by Country, 2022-2032
Figure 41: South Asia Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 42: South Asia Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 43: South Asia Alpha Emitters Market Value Share, By Country, 2022 (E)
Figure 44: South Asia Alpha Emitters Market Value Analysis (US$ Mn), 2017-2021
Figure 45: South Asia Alpha Emitters Market Value Forecast (US$ Mn), 2022-2032
Figure 46: South Asia Alpha Emitters Market Attractiveness Analysis by Type of Radionuclide, 2022-2032
Figure 47: South Asia Alpha Emitters Market Attractiveness Analysis by Application, 2022-2032
Figure 48: South Asia Alpha Emitters Market Attractiveness Analysis by Country, 2022-2032
Figure 49: East Asia Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 50: East Asia Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 51: East Asia Alpha Emitters Market Value Share, By Country, 2022 (E)
Figure 52: East Asia Alpha Emitters Market Value Analysis (US$ Mn), 2017-2021
Figure 53: East Asia Alpha Emitters Market Value Forecast (US$ Mn), 2022-2032
Figure 54: East Asia Alpha Emitters Market Attractiveness Analysis by Type of Radionuclide, 2022-2032
Figure 55: East Asia Alpha Emitters Market Attractiveness Analysis by Application, 2022-2032
Figure 56: East Asia Alpha Emitters Market Attractiveness Analysis by Country, 2022-2032
Figure 57: Oceania Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 58: Oceania Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 59: Oceania Alpha Emitters Market Value Share, By Country, 2022 (E)
Figure 60: Oceania Alpha Emitters Market Value Analysis (US$ Mn), 2017-2021
Figure 61: Oceania Alpha Emitters Market Value Forecast (US$ Mn), 2022-2032
Figure 62: Oceania Alpha Emitters Market Attractiveness Analysis by Type of Radionuclide, 2022-2032
Figure 63: Oceania Alpha Emitters Market Attractiveness Analysis by Application, 2022-2032
Figure 64: Oceania Alpha Emitters Market Attractiveness Analysis by Country, 2022-2032
Figure 65: Middle East and Africa Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 66: Middle East and Africa Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 67: Middle East and Africa Alpha Emitters Market Value Share, By Country, 2022 (E)
Figure 68: Middle East and Africa Alpha Emitters Market Value Analysis (US$ Mn), 2017-2021
Figure 69: Middle East and Africa Alpha Emitters Market Value Forecast (US$ Mn), 2022-2032
Figure 70: Middle East and Africa Alpha Emitters Market Attractiveness Analysis by Type of Radionuclide, 2022-2032
Figure 71: Middle East and Africa Alpha Emitters Market Attractiveness Analysis by Application, 2022-2032
Figure 72: Middle East and Africa Alpha Emitters Market Attractiveness Analysis by Country, 2022-2032
Figure 73: U. S. Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 74: U. S. Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 75: U. S. Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 76: Canada Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 77: Canada Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 78: Canada Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 79: Mexico Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 80: Mexico Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 81: Mexico Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 82: Brazil Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 83: Brazil Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 84: Brazil Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 85: U. K. Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 86: U. K. Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 87: U. K. Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 88: Germany Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 89: Germany Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 90: Germany Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 91: France Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 92: France Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 93: France Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 94: Italy Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 95: Italy Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 96: Italy Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 97: Spain Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 98: Spain Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 99: Spain Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 100: Russia Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 101: Russia Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 102: Russia Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 103: China Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 104: China Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 105: China Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 106: Japan Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 107: Japan Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 108: Japan Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 109: South Korea Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 110: South Korea Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 111: South Korea Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 112: India Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 113: India Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 114: India Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 115: ASEAN Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 116: ASEAN Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 117: ASEAN Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 118: Australia Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 119: Australia Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 120: Australia Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 121: New Zealand Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 122: New Zealand Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 123: New Zealand Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 124: GCC Countries Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 125: GCC Countries Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 126: GCC Countries Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 127: Turkey Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 128: Turkey Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 129: Turkey Alpha Emitters Market Value Share, By Application, 2022 (E)
Figure 130: South Africa Alpha Emitters Market Value Analysis (US$ Mn), 2022 & 2032
Figure 131: South Africa Alpha Emitters Market Value Share, By Type of Radionuclide, 2022 (E)
Figure 132: South Africa Alpha Emitters Market Value Share, By Application, 2022 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the predicted growth rate for the global alpha emitters market?
Global sales of alpha emitters are expected to surge at a CAGR of 21% from 2022 to 2032.
What is the market value of alpha emitters in 2022?
The global alpha emitters market currently accounts for a valuation of US$ 1 billion.
What is the global alpha emitters market predicted to be valued by 2032?
Worldwide demand for alpha emitters is projected to reach US$ 6.7 billion by 2032.
What is the predicted growth rate of China’s alpha emitters market?
Demand for alpha emitters in China is expected to expand at a high CAGR of 20% from 2022 to 2032.
Who are the prominent players in the global alpha emitters market?
Actinium Pharmaceuticals, Inc., Alpha Tau Medical, Bayer AG, Fusion Pharma, Lantheus Medical Imaging, IncRadioMedix, Inc., Siemens Healthineers, and Triad Isotopes, Inc. are some of the key players in the alpha emitters market.
Alpha Emitters Market